Si-Bone (SIBN) Operating Margin (2017 - 2026)
Si-Bone's (SIBN) quarterly Operating Margin came in at 9.68% in Q1 2026, up 613.0% year-on-year from 1.36% in Q1 2025, and down 121.57% quarter-over-quarter from 4.37% in Q4 2025.
Si-Bone (SIBN) Operating Margin (2017 - 2026) Analysis & Trends
Si-Bone's Operating Margin history runs 10 years deep, the most recent figure standing at 9.68% for Q1 2026.
- On a quarterly basis, Operating Margin rose 613.0% year-over-year to 9.68% in Q1 2026; TTM through Mar 2026 was 9.67%, a 770.0% increase from a year earlier, with the FY2025 full-year figure at 11.11%, up 997.0% from the prior year.
- Operating Margin eased to 9.68% in Q1 2026 per SIBN's latest filing, from 4.37% in the prior quarter.
- Across five years, Operating Margin topped out at 4.37% in Q4 2025 and bottomed at 75.17% in Q1 2022.
- The 5-year median for Operating Margin is 31.8% (2024), against an average of 29.98%.
- Across the five-year window, Operating Margin slumped 1855 bps in 2022 and jumped 4065 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 35.35% in 2022, then grew by 9 bps to 32.18% in 2023, then jumped by 65 bps to 11.21% in 2024, then soared by 61 bps to 4.37% in 2025, then tumbled by 122 bps to 9.68% in 2026.
- Per Business Quant, the three latest SIBN Operating Margin figures stand at 9.68% (Q1 2026), 4.37% (Q4 2025), and 11.06% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | -9.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.68% |
| Dec 31, 2025 | -4.37% |
| Sep 30, 2025 | -11.06% |
| Jun 30, 2025 | -14.40% |
| Mar 31, 2025 | -15.82% |
| Dec 31, 2024 | -11.21% |
| Sep 30, 2024 | -18.92% |
| Jun 30, 2024 | -25.21% |
| Mar 31, 2024 | -31.80% |
| Dec 31, 2023 | -32.18% |
| Sep 30, 2023 | -32.84% |
| Jun 30, 2023 | -35.92% |
| Mar 31, 2023 | -34.53% |
| Dec 31, 2022 | -35.35% |
| Sep 30, 2022 | -51.32% |
| Jun 30, 2022 | -69.89% |
| Mar 31, 2022 | -75.17% |
| Dec 31, 2021 | -55.22% |
| Sep 30, 2021 | -59.23% |
| Jun 30, 2021 | -58.42% |